TRexBio Closes $84M Series B to Advance Immune-Based Therapeutics
Key Highlights TRexBio raises $84M in Series B led by Delos Capital with new investors Avego BioScience and Agent…
Browsing Tag
SV Health Investors
6 posts
SpectraWAVE Secures $50M in Series B to Advance HyperVue™ Imaging System for Coronary Artery Disease Treatment
Key Highlights SpectraWAVE raises $50M in Series B led by Johnson & Johnson Innovation – JJDC, Inc. HyperVue™ Imaging…
Pulse Biosciences Appoints Paul A. LaViolette as Co-Chairman of the Board
Key Highlights Paul A. LaViolette appointed Co-Chairman of Pulse Biosciences’ Board of Directors. LaViolette brings extensive experience in…
Miach Orthopaedics Secures $20M for ACL Implant Expansion
Key Highlights $20 million Series B extension financing to propel the commercial and clinical activities of the BEAR Implant.…
Merck Acquires Caraway Therapeutics in a Landmark $610 Million Deal
Key Highlights Merck to acquire Caraway Therapeutics, a biopharmaceutical company focusing on neurodegenerative and rare diseases, for a…
EyeBio Secures $130 Million in Extended Series A Funding, Paving the Way for Advanced Retinal Disease Therapies
Key Highlights Significant Funding Achievement: EyeBio successfully closes an extension to its Series A financing, totaling $130 million. Strategic…